Simulations Plus to Participate in the Morgan Stanley 3rd Annual Life Sciences AI Summit
20 Juin 2024 - 2:30PM
Business Wire
Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a
leading provider of biosimulation, simulation-enabled performance
and intelligence solutions, and medical communications for the
biopharma industry, today announced that Shawn O’Connor, chief
executive officer, will participate in the Morgan Stanley 3rd
Annual Life Sciences AI Summit on Wednesday, June 26, 2024, at
Morgan Stanley’s headquarters in New York City. Mr. O’Connor will
join a panel discussion entitled “Transforming Research –
Optimizing from Lab to Trial” at 2:10 p.m. EDT, and he will host
one-on-one meetings with investors following the panel
discussion.
This event will feature sessions focused on the AI-driven
paradigm shift unfolding across the biopharma value chain and
discussions with some of the most influential companies operating
at the intersection of life sciences and technology innovation. For
more information about the conference, please visit the Morgan
Stanley conference website.
About Simulations Plus
With more than 25 years of experience serving clients globally,
Simulations Plus stands as a premier provider in the biopharma
sector, offering advanced software and consulting services that
enhance drug discovery, development, research, clinical trial
operations, regulatory submissions, and commercialization. Our
comprehensive biosimulation solutions integrate artificial
intelligence/machine learning (AI/ML), physiologically based
pharmacokinetics, quantitative systems pharmacology/toxicology, and
population PK/PD modeling approaches. We also deliver
simulation-enabled performance and intelligence solutions alongside
medical communications support for clinical and commercial drug
development. Our cutting-edge technology is licensed and utilized
by leading pharmaceutical, biotechnology, and regulatory agencies
worldwide. For more information, visit our website at
www.simulations-plus.com. Follow us on LinkedIn | X | YouTube.
Environmental, Social, and Governance (ESG)
We focus our Environmental, Social, and Governance (ESG) efforts
where we can have the most positive impact. To learn more about our
latest initiatives and priorities, please visit our website to read
our 2023 ESG update.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240620458052/en/
Simulations Plus Investor Relations
Renee Bouche 661-723-7723 renee.bouche@simulations-plus.com
Financial Profiles Lisa Fortuna
310-622-8251 slp@finprofiles.com
Simulations Plus (NASDAQ:SLP)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Simulations Plus (NASDAQ:SLP)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024